Regencell Bioscience Holdings LimitedRGC

$12.01-2.81 (-18.96%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$6B

Mid-cap

+11282%

2021 — today

10-Year Price

+8647%

2021 — today

52-Week Range

$10.36$52.88

Current $12.01· 4%

Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.

Valuation in context

P/E ratio

-536.2

N/A

Not meaningful — company is unprofitable

P/B ratio

4,870.2

Near historic high

Near historic highs — last 10 years

Free · No credit card needed

Get alerted when RGC is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.